InsidersTradesSigma
Follow the SYN2BIO S.A. stock price and the full insider trade history of the company, a publicly traded company based in Poland. Shares are listed on the PL market, under the authority of KNF. Operating in the Health Care sector, SYN2BIO S.A. has recorded 4 reports. Market capitalisation: €579.6m. The latest transaction was reported on 18 May 2026 (Notification PDMR). All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
SYN2BIO S.A. is a company specializing in the health and pharmaceutical sector. It is listed on the XWAR market.